日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Randomized Controlled Trial: Evaluating the Sleep, Cancer and Rest (SleepCaRe) Trial to Improve Health-Related Quality of Life in Women Undergoing Chemotherapy for Breast Cancer

一项随机对照试验：评估睡眠、癌症和休息（SleepCaRe）试验对接受乳腺癌化疗女性健康相关生活质量的改善作用

期刊:Psycho-Oncology
影响因子:3.5
doi:10.1002/pon.70418
Wallace, Rebecca; Alexander, Marliese; Day, Daphne; Diggens, Justine; Ftanou, Maria; Aedo-Lopez, Veronica; Bei, Bei; Blum, Robert; Boyle, Frances; Do, Trang Thuy; Francis, Prudence A; Garland, Sheila N; Maccora, Jordan; Sharma, Sharad; Stafford, Lesley; White, Michelle; Mortimer, Duncan; Wiley, Joshua F
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Retrospective comprehensive analysis of regional lymph node recurrence in breast cancer patients (REASON study)

乳腺癌患者区域淋巴结复发的回顾性综合分析（REASON 研究）

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-025-06235-5
Liapi, Aikaterini; Aedo-Lopez, Veronica; Jeanneret-Sozzi, Wendy; Stravodimou, Athina; Prior, John O; Lalonde, Marie Nicod; Treboux, Assia Ifticene; Lelievre, Loic; Kandalaft, Lana; Rossier, Laetitia; Goupil, Audrey; Bergomi, Marzio; Rivals, Jean-Paul; Brouland, Jean-Philippe; Curtit, Elsa; Meuwly, Jean-Yves; Zaman, Khalil
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

A pharmacist-led interprofessional medication adherence program improved adherence to oral anticancer therapies: The OpTAT randomized controlled trial

一项由药剂师主导的跨专业药物依从性计划提高了口服抗癌疗法的依从性：OpTAT随机对照试验

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0304573
Bandiera, Carole; Cardoso, Evelina; Locatelli, Isabella; Zaman, Khalil; Diciolla, Antonella; Digklia, Antonia; Stravodimou, Athina; Cristina, Valérie; Aedo-Lopez, Veronica; Dolcan, Ana; Sarivalasis, Apostolos; Bouchaab, Hasna; Pasquier, Jérôme; Dotta-Celio, Jennifer; Peters, Solange; Wagner, Dorothea; Csajka, Chantal; Schneider, Marie Paule
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma

MAP2K1突变型三阴性黑色素瘤对曲美替尼的反应和耐药性

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms24054520
Krebs, Fanny Seraphine; Moura, Bianca; Missiaglia, Edoardo; Aedo-Lopez, Veronica; Michielin, Olivier; Tsantoulis, Petros; Bisig, Bettina; Trimech, Mounir; Zoete, Vincent; Homicsko, Krisztian
黑色素瘤
MAP2
发表日期：2023
文献求助 收藏

Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study

OpTAT 研究中，药代动力学模型支持患者坚持服用 CDK 4/6 抑制剂帕博西尼，并省略剂量管理。

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers15010316
Bandiera, Carole; Locatelli, Isabella; Courlet, Perrine; Cardoso, Evelina; Zaman, Khalil; Stravodimou, Athina; Dolcan, Ana; Sarivalasis, Apostolos; Zurcher, Jean-Philippe; Aedo-Lopez, Veronica; Dotta-Celio, Jennifer; Peters, Solange; Guidi, Monia; Wagner, Anna Dorothea; Csajka, Chantal; Schneider, Marie P
发表日期：2023
文献求助 收藏

Development of an eHealth-enhanced model of care for the monitoring and management of immune-related adverse events in patients treated with immune checkpoint inhibitors

开发一种基于电子健康技术的护理模式，用于监测和管理接受免疫检查点抑制剂治疗的患者发生的免疫相关不良事件

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-023-07934-w
da Silva Lopes, André Manuel; Colomer-Lahiguera, Sara; Darnac, Célia; Giacomini, Stellio; Bugeia, Sébastien; Gutknecht, Garance; Spurrier-Bernard, Gilliosa; Aedo-Lopez, Veronica; Mederos, Nuria; Latifyan, Sofiya; Addedo, Alfredo; Michielin, Olivier; Eicher, Manuela
免疫/内分泌
发表日期：2023
文献求助 收藏

Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

基于电子患者报告结果的免疫检查点抑制剂患者护理模式测试：一项随机II期对照试验方案

期刊:JMIR Research Protocols
影响因子:1.5
doi:10.2196/48386
da Silva Lopes, André Manuel; Colomer-Lahiguera, Sara; Darnac, Célia; Giacomini, Stellio; Bugeia, Sébastien; Gutknecht, Garance; Spurrier-Bernard, Gilliosa; Cuendet, Michel; Muet, Fanny; Aedo-Lopez, Veronica; Mederos, Nuria; Michielin, Olivier; Addeo, Alfredo; Latifyan, Sofiya; Eicher, Manuela
Checkpoint
免疫/内分泌
发表日期：2023
文献求助 收藏

Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma

伊匹木单抗联合纳武利尤单抗及序贯选择性内放射治疗治疗肝内和肝外转移性葡萄膜黑色素瘤的安全性和有效性

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14051162
Aedo-Lopez, Veronica; Gérard, Camille L; Boughdad, Sarah; Gautron Moura, Bianca; Berthod, Gregoire; Digklia, Antonia; Homicsko, Krisztian; Schaefer, Niklaus; Duran, Rafael; Cuendet, Michel A; Michielin, Olivier
黑色素瘤
发表日期：2022
文献求助 收藏

Gender profile of principal investigators in a large academic clinical trials group

大型学术临床试验组主要研究者的性别构成

期刊:Frontiers in Surgery
影响因子:1.8
doi:10.3389/fsurg.2022.962120
Luong, Vi Thi Thao; Ho, Cindy; Aedo-Lopez, Veronica; Segelov, Eva
发表日期：2022
文献求助 收藏

Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

在奥地利、瑞士和德国的医疗中心，talimogene laherparepvec (T-VEC) 在黑色素瘤患者中的实际应用

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-001701
Ressler, Julia Maria; Karasek, Matthias; Koch, Lukas; Silmbrod, Rita; Mangana, Joanna; Latifyan, Sofiya; Aedo-Lopez, Veronica; Kehrer, Helmut; Weihsengruber, Felix; Koelblinger, Peter; Posch, Christian; Kofler, Julian; Michielin, Olivier; Richtig, Erika; Hafner, Christine; Hoeller, Christoph
黑色素瘤
发表日期：2021
文献求助 收藏